Latest filing published 20 Jul 2023 for GSK plc, €9,530.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
D Redfern: trading record in brief
D Redfern discloses dealings in GSK plc to RNS (LSE). We count 15 filings; the first trade dates from 9 August 2022 and the latest from 18 July 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 20 July 2023 came the latest disclosure, a share grant for €9,530 in GSK plc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to D Redfern
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 616 shares@ £13.3082.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-7
- 0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-19Canonical exit: 16 Oct 2023 (T+90)
- 20 shares@ £13.2582.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-15Canonical exit: 12 Oct 2023 (T+90)
- 70 shares@ £13.35319.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-6Canonical exit: 11 Oct 2023 (T+90)
- 18 shares@ £13.06722.4% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4835002-4Canonical exit: 9 Oct 2023 (T+90)
- 18 shares@ £13.79672.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4799763-4Canonical exit: 7 Sept 2023 (T+90)
6 of 6 declarations
